These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16849557)

  • 21. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
    Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
    Donato LJ; Noy N
    Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of human tumor cells to retinoids or combined treatment with retinoids and ionizing radiation is not dependent on RAR-beta 2 induction.
    Blaese MA; Santo-Hoeltje L; Rodemann HP
    Strahlenther Onkol; 2003 Jun; 179(6):401-9. PubMed ID: 12789467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel human esophagus-specific gene c1orf10: cDNA cloning, gene structure, and frequent loss of expression in esophageal cancer.
    Xu Z; Wang MR; Xu X; Cai Y; Han YL; Wu KM; Wang J; Chen BS; Wang XQ; Wu M
    Genomics; 2000 Nov; 69(3):322-30. PubMed ID: 11056050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular cloning and functional analysis of STGC3 - a novel gene on chromosome 3p21].
    He XS; Xiao ZQ; Chen ZC; Zhao SP; Zhu JH; He ZM; Li YJ; Tian F; Yu YH
    Ai Zheng; 2004 Oct; 23(10):1110-5. PubMed ID: 15473918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma.
    Yang Q; Sakurai T; Yoshimura G; Mori I; Nakamura M; Nakamura Y; Suzuma T; Tamaki T; Umemura T; Kakudo K
    Anticancer Res; 2001; 21(3B):1829-33. PubMed ID: 11497266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of retinoic acid receptor-beta mRNA and p16, p53, Ki67 proteins in esophageal carcinoma and its precursor lesions].
    Huang H; Wang LF; Tian HM; Liu Y; Li M; Qu P; Wang WR; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):152-5. PubMed ID: 15946564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of the RAR interaction domain of cellular retinoic acid binding protein-II.
    Budhu A; Gillilan R; Noy N
    J Mol Biol; 2001 Jan; 305(4):939-49. PubMed ID: 11162104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation.
    Seo SY; Kim EO; Jang KL
    Cancer Lett; 2008 Oct; 270(1):66-76. PubMed ID: 18539384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of retinoic acid receptor-beta isoforms during chick limb ontogeny.
    Smith SM; Kirstein IJ; Wang ZS; Fallon JF; Kelley J; Bradshaw-Rouse J
    Dev Dyn; 1995 Jan; 202(1):54-66. PubMed ID: 7703521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2.
    Song S; Guan B; Men T; Hoque A; Lotan R; Xu XC
    Cancer Prev Res (Phila); 2009 Mar; 2(3):274-80. PubMed ID: 19258542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
    Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
    Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor.
    Yang Q; Wang R; Xiao W; Sun F; Yuan H; Pan Q
    PLoS One; 2016; 11(2):e0148381. PubMed ID: 26839961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity.
    Wang Y; Chen Y; Chen M; Xu W
    Oncol Rep; 2006 Oct; 16(4):755-61. PubMed ID: 16969490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
    Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.